Assessment of aortic elastic properties in patients with sarcoidosis

References

• Reich JM. What is sarcoidosis? Chest. 2003;124:367–171.
   PubMed Web of Science ®Google Scholar
• Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J. 2008;38:270–277.
   Google Scholar
• Ardic I, Kaya MG, Yarlioglues M, Dogdu O, Buyukoglan H, Kalay N, . Impaired heart rate recovery index in patients with sarcoidosis. Chest. 2011;139:60–68.
   PubMed Web of Science ®Google Scholar
• Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004;90:37–43.
   PubMed Web of Science ®Google Scholar
• Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, . Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–1241.
   PubMed Web of Science ®Google Scholar
• Tavil Y, Oztürk MA, Ureten K, Sen N, Kaya MG, Cemri M, . Assessment of aortic wall stiffness in patients with familial Mediterranean fever. Joint Bone Spine. 2008;75:280–285.
   PubMedGoogle Scholar
• Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, . Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol 2007;50:852–858.
   PubMed Web of Science ®Google Scholar
• Ardic I, Kaya MG, Yarlioglues M, Karadag Z, Dogan A, Yildiz H, . Impaired aortic elastic properties in normotensive patients with psoriasis. Blood Press. 2010;19:351–358.
   PubMed Web of Science ®Google Scholar
• Dogdu O, Kaya MG, Yarlioglues M, Dogan A, Ardic I, Elcik D, . Impaired aortic elastic properties in patients with chronic graft-versus-host disease. Echocardiography 2011;28: 1011–1018.
   Google Scholar
• Moyssakis I, Gialafos E, Tentolouris N, Floudas CS, Papaioannou TG, Kostopoulos Ch, . Impaired aortic elastic properties in patients with systemic sarcoidosis. Eur J Clin Invest. 2008;38:82–89.
   Google Scholar
• Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736–755.
   PubMed Web of Science ®Google Scholar
• Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr. 2002;15:167–184.
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta: Comparison of invasive and non-invasive techniques in healthy men and in men with arterial disease. Eur Heart J. 1990;11:990–996.
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, . ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:149–173.
   PubMed Web of Science ®Google Scholar
• Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: Diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther. 1996;10:495–510.
   Google Scholar
• Homsi M, Alsayed L, Safadi B, Mahenthiran J, Das MK. Fragmented QRS complexes on 12-lead ECG: A marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann Noninvasive Electrocardiol. 2009;14:319–326.
   PubMed Web of Science ®Google Scholar
• Uyarel H, Uslu N, Okmen E, Tartan Z, Kasikcioglu H, Dayi SU, . QT dispersion in sarcoidosis. Chest. 2005;128: 2619–2625.
   Google Scholar
• Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, . Cardiac cycle dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol. 2001;38:796–802.
   PubMed Web of Science ®Google Scholar
• O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45:652–658.
   PubMed Web of Science ®Google Scholar
• Ng WF, Fantin F, Ng C, Dockery F, Schiff R, Davies KA, . Takayasu's arteritis: A cause of prolonged arterial stiffness. Rheumatology (Oxford). 2006;45:741–745.
   PubMed Web of Science ®Google Scholar
• Tunc SE, Dogan A, Gedikli O, Arslan C, Sahin M. Assessment of aortic stiffness and ventricular diastolic functions in patients with Behçet's disease. Rheumatol Int. 2005;25:447–451.
   PubMed Web of Science ®Google Scholar
• Timár O, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, . Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol. 2008;35: 1329–1333.
   PubMedGoogle Scholar
• Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: A randomized controlled trial. J Am Coll Cardiol. 2009;54:505–512.
   PubMed Web of Science ®Google Scholar
• Maksimowicz-McKinnon K, Hoffman GS. Large-vessel vasculitis. Semin Respir Crit Care Med. 2004;25:569–579.
   Google Scholar
• Fernandes SR, Singsen BH, Hoffman GS. Sarcoidosis and systemic vasculitis. Semin Arthritis Rheum. 2000;30:33–46.
   Google Scholar
• Baughman RP, Lower EE, Drent M. Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis. 2008;25:76–89.
   PubMed Web of Science ®Google Scholar
• Fireman E, Gilburd D, Marmor S. Angiogenic cytokines in induced sputum of patients with sarcoidosis. Respirology. 2009;14:117–123.
   Google Scholar
• Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E. Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. J Physiol Pharmacol. 2008;59:507–513.
   PubMedGoogle Scholar
• Boots AW, Drent M, Swennen EL, Moonen HJ, Bast A, Haenen GR. Antioxidant status associated with inflammation in sarcoidosis: A potential role for antioxidants. Respir Med. 2009;103:364–372.
   PubMed Web of Science ®Google Scholar
• Katsuda S, Okada Y, Okada Y, Imai K, Nakanishi I. Matrix metalloproteinase 9 (92-kd gelatinase/type IV collagenase) can degrade arterial elastin. Am J Pathol. 1994;144:1208–1218.
   Google Scholar